Global Molecular Oncology Market Growth (Status and Outlook) 2026-2032
The global Molecular Oncology market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Molecular diagnostics in cancer is becoming more and more common in clinical laboratories. Targeted therapy possibilities for malignancies such as multiple myeloma, lymphoma, melanoma, lung, breast, ovarian, prostate, and others are now being assessed using molecular oncology assays.Molecular oncology researchers use a variety of methods, including as in-vitro and in vivo functional models, computational biology, genomics, and tumor imaging, to comprehend biological and clinical characteristics.The genes that produce these proteins may be used as targets in the development of novel anti-cancer medications, chemotherapeutic medicines, or imaging scans. These combinatorial methods are used in molecular oncology to confirm the involvement of novel candidate genes in the genesis of cancer.
United States market for Molecular Oncology is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Molecular Oncology is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Molecular Oncology is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Molecular Oncology players cover Roche Diagnostics, Thermo Fisher Scientific Inc., Illumina, Inc., Qiagen N.V., Agilent Technologies, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Molecular Oncology Industry Forecast” looks at past sales and reviews total world Molecular Oncology sales in 2025, providing a comprehensive analysis by region and market sector of projected Molecular Oncology sales for 2026 through 2032. With Molecular Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Oncology industry.
This Insight Report provides a comprehensive analysis of the global Molecular Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Oncology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Oncology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Oncology.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Oncology market by product type, application, key players and key regions and countries.
Segmentation by Type:
The report requires updating with new data and is sent in 48 hours after order is placed.
Molecular diagnostics in cancer is becoming more and more common in clinical laboratories. Targeted therapy possibilities for malignancies such as multiple myeloma, lymphoma, melanoma, lung, breast, ovarian, prostate, and others are now being assessed using molecular oncology assays.Molecular oncology researchers use a variety of methods, including as in-vitro and in vivo functional models, computational biology, genomics, and tumor imaging, to comprehend biological and clinical characteristics.The genes that produce these proteins may be used as targets in the development of novel anti-cancer medications, chemotherapeutic medicines, or imaging scans. These combinatorial methods are used in molecular oncology to confirm the involvement of novel candidate genes in the genesis of cancer.
United States market for Molecular Oncology is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Molecular Oncology is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Molecular Oncology is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Molecular Oncology players cover Roche Diagnostics, Thermo Fisher Scientific Inc., Illumina, Inc., Qiagen N.V., Agilent Technologies, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Molecular Oncology Industry Forecast” looks at past sales and reviews total world Molecular Oncology sales in 2025, providing a comprehensive analysis by region and market sector of projected Molecular Oncology sales for 2026 through 2032. With Molecular Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Oncology industry.
This Insight Report provides a comprehensive analysis of the global Molecular Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Oncology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Oncology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Oncology.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Oncology market by product type, application, key players and key regions and countries.
Segmentation by Type:
- PCR
- NGS (Next Generation Sequencing)
- Microarray
- FISH (Fluorescent in situ-hybridization)
- Others
- Hospitals and Clinics
- Diagnostic Laboratories
- Cancer Centers and Specialty Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche Diagnostics
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Qiagen N.V.
- Agilent Technologies, Inc.
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Myriad Genetics, Inc.
- Genomic Health, Inc.
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Oncology Market Size (2021-2032)
2.1.2 Molecular Oncology Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Molecular Oncology by Country/Region (2021, 2025 & 2032)
2.2 Molecular Oncology Segment by Type
2.2.1 PCR
2.2.2 NGS (Next Generation Sequencing)
2.2.3 Microarray
2.2.4 FISH (Fluorescent in situ-hybridization)
2.2.5 Others
2.2.6 Molecular Oncology Market Size by Type
2.2.6.1 Molecular Oncology Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Molecular Oncology Market Size Market Share by Type (2021-2026)
2.3 Molecular Oncology Segment by Application
2.3.1 Hospitals and Clinics
2.3.2 Diagnostic Laboratories
2.3.3 Cancer Centers and Specialty Clinics
2.3.4 Others
2.3.5 Molecular Oncology Market Size by Application
2.3.5.1 Molecular Oncology Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Molecular Oncology Market Size Market Share by Application (2021-2026)
3 MOLECULAR ONCOLOGY MARKET SIZE BY PLAYER
3.1 Molecular Oncology Market Size Market Share by Player
3.1.1 Global Molecular Oncology Revenue by Player (2021-2026)
3.1.2 Global Molecular Oncology Revenue Market Share by Player (2021-2026)
3.2 Global Molecular Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR ONCOLOGY BY REGION
4.1 Molecular Oncology Market Size by Region (2021-2026)
4.2 Global Molecular Oncology Annual Revenue by Country/Region (2021-2026)
4.3 Americas Molecular Oncology Market Size Growth (2021-2026)
4.4 APAC Molecular Oncology Market Size Growth (2021-2026)
4.5 Europe Molecular Oncology Market Size Growth (2021-2026)
4.6 Middle East & Africa Molecular Oncology Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Molecular Oncology Market Size by Country (2021-2026)
5.2 Americas Molecular Oncology Market Size by Type (2021-2026)
5.3 Americas Molecular Oncology Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Oncology Market Size by Region (2021-2026)
6.2 APAC Molecular Oncology Market Size by Type (2021-2026)
6.3 APAC Molecular Oncology Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Oncology Market Size by Country (2021-2026)
7.2 Europe Molecular Oncology Market Size by Type (2021-2026)
7.3 Europe Molecular Oncology Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Oncology by Region (2021-2026)
8.2 Middle East & Africa Molecular Oncology Market Size by Type (2021-2026)
8.3 Middle East & Africa Molecular Oncology Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR ONCOLOGY MARKET FORECAST
10.1 Global Molecular Oncology Forecast by Region (2027-2032)
10.1.1 Global Molecular Oncology Forecast by Region (2027-2032)
10.1.2 Americas Molecular Oncology Forecast
10.1.3 APAC Molecular Oncology Forecast
10.1.4 Europe Molecular Oncology Forecast
10.1.5 Middle East & Africa Molecular Oncology Forecast
10.2 Americas Molecular Oncology Forecast by Country (2027-2032)
10.2.1 United States Market Molecular Oncology Forecast
10.2.2 Canada Market Molecular Oncology Forecast
10.2.3 Mexico Market Molecular Oncology Forecast
10.2.4 Brazil Market Molecular Oncology Forecast
10.3 APAC Molecular Oncology Forecast by Region (2027-2032)
10.3.1 China Molecular Oncology Market Forecast
10.3.2 Japan Market Molecular Oncology Forecast
10.3.3 Korea Market Molecular Oncology Forecast
10.3.4 Southeast Asia Market Molecular Oncology Forecast
10.3.5 India Market Molecular Oncology Forecast
10.3.6 Australia Market Molecular Oncology Forecast
10.4 Europe Molecular Oncology Forecast by Country (2027-2032)
10.4.1 Germany Market Molecular Oncology Forecast
10.4.2 France Market Molecular Oncology Forecast
10.4.3 UK Market Molecular Oncology Forecast
10.4.4 Italy Market Molecular Oncology Forecast
10.4.5 Russia Market Molecular Oncology Forecast
10.5 Middle East & Africa Molecular Oncology Forecast by Region (2027-2032)
10.5.1 Egypt Market Molecular Oncology Forecast
10.5.2 South Africa Market Molecular Oncology Forecast
10.5.3 Israel Market Molecular Oncology Forecast
10.5.4 Turkey Market Molecular Oncology Forecast
10.6 Global Molecular Oncology Forecast by Type (2027-2032)
10.7 Global Molecular Oncology Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Molecular Oncology Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Information
11.1.2 Roche Diagnostics Molecular Oncology Product Offered
11.1.3 Roche Diagnostics Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Roche Diagnostics Main Business Overview
11.1.5 Roche Diagnostics Latest Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Information
11.2.2 Thermo Fisher Scientific Inc. Molecular Oncology Product Offered
11.2.3 Thermo Fisher Scientific Inc. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific Inc. Latest Developments
11.3 Illumina, Inc.
11.3.1 Illumina, Inc. Company Information
11.3.2 Illumina, Inc. Molecular Oncology Product Offered
11.3.3 Illumina, Inc. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina, Inc. Main Business Overview
11.3.5 Illumina, Inc. Latest Developments
11.4 Qiagen N.V.
11.4.1 Qiagen N.V. Company Information
11.4.2 Qiagen N.V. Molecular Oncology Product Offered
11.4.3 Qiagen N.V. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Qiagen N.V. Main Business Overview
11.4.5 Qiagen N.V. Latest Developments
11.5 Agilent Technologies, Inc.
11.5.1 Agilent Technologies, Inc. Company Information
11.5.2 Agilent Technologies, Inc. Molecular Oncology Product Offered
11.5.3 Agilent Technologies, Inc. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Agilent Technologies, Inc. Main Business Overview
11.5.5 Agilent Technologies, Inc. Latest Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Information
11.6.2 Abbott Laboratories Molecular Oncology Product Offered
11.6.3 Abbott Laboratories Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Abbott Laboratories Main Business Overview
11.6.5 Abbott Laboratories Latest Developments
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Information
11.7.2 Bio-Rad Laboratories, Inc. Molecular Oncology Product Offered
11.7.3 Bio-Rad Laboratories, Inc. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.7.5 Bio-Rad Laboratories, Inc. Latest Developments
11.8 Myriad Genetics, Inc.
11.8.1 Myriad Genetics, Inc. Company Information
11.8.2 Myriad Genetics, Inc. Molecular Oncology Product Offered
11.8.3 Myriad Genetics, Inc. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Myriad Genetics, Inc. Main Business Overview
11.8.5 Myriad Genetics, Inc. Latest Developments
11.9 Genomic Health, Inc.
11.9.1 Genomic Health, Inc. Company Information
11.9.2 Genomic Health, Inc. Molecular Oncology Product Offered
11.9.3 Genomic Health, Inc. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Genomic Health, Inc. Main Business Overview
11.9.5 Genomic Health, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Molecular Oncology Market Size (2021-2032)
2.1.2 Molecular Oncology Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Molecular Oncology by Country/Region (2021, 2025 & 2032)
2.2 Molecular Oncology Segment by Type
2.2.1 PCR
2.2.2 NGS (Next Generation Sequencing)
2.2.3 Microarray
2.2.4 FISH (Fluorescent in situ-hybridization)
2.2.5 Others
2.2.6 Molecular Oncology Market Size by Type
2.2.6.1 Molecular Oncology Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Molecular Oncology Market Size Market Share by Type (2021-2026)
2.3 Molecular Oncology Segment by Application
2.3.1 Hospitals and Clinics
2.3.2 Diagnostic Laboratories
2.3.3 Cancer Centers and Specialty Clinics
2.3.4 Others
2.3.5 Molecular Oncology Market Size by Application
2.3.5.1 Molecular Oncology Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Molecular Oncology Market Size Market Share by Application (2021-2026)
3 MOLECULAR ONCOLOGY MARKET SIZE BY PLAYER
3.1 Molecular Oncology Market Size Market Share by Player
3.1.1 Global Molecular Oncology Revenue by Player (2021-2026)
3.1.2 Global Molecular Oncology Revenue Market Share by Player (2021-2026)
3.2 Global Molecular Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MOLECULAR ONCOLOGY BY REGION
4.1 Molecular Oncology Market Size by Region (2021-2026)
4.2 Global Molecular Oncology Annual Revenue by Country/Region (2021-2026)
4.3 Americas Molecular Oncology Market Size Growth (2021-2026)
4.4 APAC Molecular Oncology Market Size Growth (2021-2026)
4.5 Europe Molecular Oncology Market Size Growth (2021-2026)
4.6 Middle East & Africa Molecular Oncology Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Molecular Oncology Market Size by Country (2021-2026)
5.2 Americas Molecular Oncology Market Size by Type (2021-2026)
5.3 Americas Molecular Oncology Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Oncology Market Size by Region (2021-2026)
6.2 APAC Molecular Oncology Market Size by Type (2021-2026)
6.3 APAC Molecular Oncology Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Molecular Oncology Market Size by Country (2021-2026)
7.2 Europe Molecular Oncology Market Size by Type (2021-2026)
7.3 Europe Molecular Oncology Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Molecular Oncology by Region (2021-2026)
8.2 Middle East & Africa Molecular Oncology Market Size by Type (2021-2026)
8.3 Middle East & Africa Molecular Oncology Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MOLECULAR ONCOLOGY MARKET FORECAST
10.1 Global Molecular Oncology Forecast by Region (2027-2032)
10.1.1 Global Molecular Oncology Forecast by Region (2027-2032)
10.1.2 Americas Molecular Oncology Forecast
10.1.3 APAC Molecular Oncology Forecast
10.1.4 Europe Molecular Oncology Forecast
10.1.5 Middle East & Africa Molecular Oncology Forecast
10.2 Americas Molecular Oncology Forecast by Country (2027-2032)
10.2.1 United States Market Molecular Oncology Forecast
10.2.2 Canada Market Molecular Oncology Forecast
10.2.3 Mexico Market Molecular Oncology Forecast
10.2.4 Brazil Market Molecular Oncology Forecast
10.3 APAC Molecular Oncology Forecast by Region (2027-2032)
10.3.1 China Molecular Oncology Market Forecast
10.3.2 Japan Market Molecular Oncology Forecast
10.3.3 Korea Market Molecular Oncology Forecast
10.3.4 Southeast Asia Market Molecular Oncology Forecast
10.3.5 India Market Molecular Oncology Forecast
10.3.6 Australia Market Molecular Oncology Forecast
10.4 Europe Molecular Oncology Forecast by Country (2027-2032)
10.4.1 Germany Market Molecular Oncology Forecast
10.4.2 France Market Molecular Oncology Forecast
10.4.3 UK Market Molecular Oncology Forecast
10.4.4 Italy Market Molecular Oncology Forecast
10.4.5 Russia Market Molecular Oncology Forecast
10.5 Middle East & Africa Molecular Oncology Forecast by Region (2027-2032)
10.5.1 Egypt Market Molecular Oncology Forecast
10.5.2 South Africa Market Molecular Oncology Forecast
10.5.3 Israel Market Molecular Oncology Forecast
10.5.4 Turkey Market Molecular Oncology Forecast
10.6 Global Molecular Oncology Forecast by Type (2027-2032)
10.7 Global Molecular Oncology Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Molecular Oncology Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Information
11.1.2 Roche Diagnostics Molecular Oncology Product Offered
11.1.3 Roche Diagnostics Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Roche Diagnostics Main Business Overview
11.1.5 Roche Diagnostics Latest Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Information
11.2.2 Thermo Fisher Scientific Inc. Molecular Oncology Product Offered
11.2.3 Thermo Fisher Scientific Inc. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific Inc. Latest Developments
11.3 Illumina, Inc.
11.3.1 Illumina, Inc. Company Information
11.3.2 Illumina, Inc. Molecular Oncology Product Offered
11.3.3 Illumina, Inc. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina, Inc. Main Business Overview
11.3.5 Illumina, Inc. Latest Developments
11.4 Qiagen N.V.
11.4.1 Qiagen N.V. Company Information
11.4.2 Qiagen N.V. Molecular Oncology Product Offered
11.4.3 Qiagen N.V. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Qiagen N.V. Main Business Overview
11.4.5 Qiagen N.V. Latest Developments
11.5 Agilent Technologies, Inc.
11.5.1 Agilent Technologies, Inc. Company Information
11.5.2 Agilent Technologies, Inc. Molecular Oncology Product Offered
11.5.3 Agilent Technologies, Inc. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Agilent Technologies, Inc. Main Business Overview
11.5.5 Agilent Technologies, Inc. Latest Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Information
11.6.2 Abbott Laboratories Molecular Oncology Product Offered
11.6.3 Abbott Laboratories Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Abbott Laboratories Main Business Overview
11.6.5 Abbott Laboratories Latest Developments
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Information
11.7.2 Bio-Rad Laboratories, Inc. Molecular Oncology Product Offered
11.7.3 Bio-Rad Laboratories, Inc. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.7.5 Bio-Rad Laboratories, Inc. Latest Developments
11.8 Myriad Genetics, Inc.
11.8.1 Myriad Genetics, Inc. Company Information
11.8.2 Myriad Genetics, Inc. Molecular Oncology Product Offered
11.8.3 Myriad Genetics, Inc. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Myriad Genetics, Inc. Main Business Overview
11.8.5 Myriad Genetics, Inc. Latest Developments
11.9 Genomic Health, Inc.
11.9.1 Genomic Health, Inc. Company Information
11.9.2 Genomic Health, Inc. Molecular Oncology Product Offered
11.9.3 Genomic Health, Inc. Molecular Oncology Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Genomic Health, Inc. Main Business Overview
11.9.5 Genomic Health, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Molecular Oncology Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Molecular Oncology Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of PCR
Table 4. Major Players of NGS (Next Generation Sequencing)
Table 5. Major Players of Microarray
Table 6. Major Players of FISH (Fluorescent in situ-hybridization)
Table 7. Major Players of Others
Table 8. Molecular Oncology Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Molecular Oncology Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Molecular Oncology Market Size Market Share by Type (2021-2026)
Table 11. Molecular Oncology Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Molecular Oncology Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Molecular Oncology Market Size Market Share by Application (2021-2026)
Table 14. Global Molecular Oncology Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Molecular Oncology Revenue Market Share by Player (2021-2026)
Table 16. Molecular Oncology Key Players Head office and Products Offered
Table 17. Molecular Oncology Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Molecular Oncology Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Molecular Oncology Market Size Market Share by Region (2021-2026)
Table 22. Global Molecular Oncology Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Molecular Oncology Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Molecular Oncology Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Molecular Oncology Market Size Market Share by Country (2021-2026)
Table 26. Americas Molecular Oncology Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Molecular Oncology Market Size Market Share by Type (2021-2026)
Table 28. Americas Molecular Oncology Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Molecular Oncology Market Size Market Share by Application (2021-2026)
Table 30. APAC Molecular Oncology Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Molecular Oncology Market Size Market Share by Region (2021-2026)
Table 32. APAC Molecular Oncology Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Molecular Oncology Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Molecular Oncology Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Molecular Oncology Market Size Market Share by Country (2021-2026)
Table 36. Europe Molecular Oncology Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Molecular Oncology Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Molecular Oncology Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Molecular Oncology Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Molecular Oncology Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Molecular Oncology
Table 42. Key Market Challenges & Risks of Molecular Oncology
Table 43. Key Industry Trends of Molecular Oncology
Table 44. Global Molecular Oncology Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Molecular Oncology Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Molecular Oncology Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Molecular Oncology Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Roche Diagnostics Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 49. Roche Diagnostics Molecular Oncology Product Offered
Table 50. Roche Diagnostics Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Roche Diagnostics Main Business
Table 52. Roche Diagnostics Latest Developments
Table 53. Thermo Fisher Scientific Inc. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 54. Thermo Fisher Scientific Inc. Molecular Oncology Product Offered
Table 55. Thermo Fisher Scientific Inc. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Thermo Fisher Scientific Inc. Main Business
Table 57. Thermo Fisher Scientific Inc. Latest Developments
Table 58. Illumina, Inc. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 59. Illumina, Inc. Molecular Oncology Product Offered
Table 60. Illumina, Inc. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Illumina, Inc. Main Business
Table 62. Illumina, Inc. Latest Developments
Table 63. Qiagen N.V. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 64. Qiagen N.V. Molecular Oncology Product Offered
Table 65. Qiagen N.V. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Qiagen N.V. Main Business
Table 67. Qiagen N.V. Latest Developments
Table 68. Agilent Technologies, Inc. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 69. Agilent Technologies, Inc. Molecular Oncology Product Offered
Table 70. Agilent Technologies, Inc. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Agilent Technologies, Inc. Main Business
Table 72. Agilent Technologies, Inc. Latest Developments
Table 73. Abbott Laboratories Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 74. Abbott Laboratories Molecular Oncology Product Offered
Table 75. Abbott Laboratories Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Abbott Laboratories Main Business
Table 77. Abbott Laboratories Latest Developments
Table 78. Bio-Rad Laboratories, Inc. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 79. Bio-Rad Laboratories, Inc. Molecular Oncology Product Offered
Table 80. Bio-Rad Laboratories, Inc. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Bio-Rad Laboratories, Inc. Main Business
Table 82. Bio-Rad Laboratories, Inc. Latest Developments
Table 83. Myriad Genetics, Inc. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 84. Myriad Genetics, Inc. Molecular Oncology Product Offered
Table 85. Myriad Genetics, Inc. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Myriad Genetics, Inc. Main Business
Table 87. Myriad Genetics, Inc. Latest Developments
Table 88. Genomic Health, Inc. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 89. Genomic Health, Inc. Molecular Oncology Product Offered
Table 90. Genomic Health, Inc. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Genomic Health, Inc. Main Business
Table 92. Genomic Health, Inc. Latest Developments
Table 1. Molecular Oncology Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Molecular Oncology Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of PCR
Table 4. Major Players of NGS (Next Generation Sequencing)
Table 5. Major Players of Microarray
Table 6. Major Players of FISH (Fluorescent in situ-hybridization)
Table 7. Major Players of Others
Table 8. Molecular Oncology Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Molecular Oncology Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Molecular Oncology Market Size Market Share by Type (2021-2026)
Table 11. Molecular Oncology Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Molecular Oncology Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Molecular Oncology Market Size Market Share by Application (2021-2026)
Table 14. Global Molecular Oncology Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Molecular Oncology Revenue Market Share by Player (2021-2026)
Table 16. Molecular Oncology Key Players Head office and Products Offered
Table 17. Molecular Oncology Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Molecular Oncology Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Molecular Oncology Market Size Market Share by Region (2021-2026)
Table 22. Global Molecular Oncology Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Molecular Oncology Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Molecular Oncology Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Molecular Oncology Market Size Market Share by Country (2021-2026)
Table 26. Americas Molecular Oncology Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Molecular Oncology Market Size Market Share by Type (2021-2026)
Table 28. Americas Molecular Oncology Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Molecular Oncology Market Size Market Share by Application (2021-2026)
Table 30. APAC Molecular Oncology Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Molecular Oncology Market Size Market Share by Region (2021-2026)
Table 32. APAC Molecular Oncology Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Molecular Oncology Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Molecular Oncology Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Molecular Oncology Market Size Market Share by Country (2021-2026)
Table 36. Europe Molecular Oncology Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Molecular Oncology Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Molecular Oncology Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Molecular Oncology Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Molecular Oncology Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Molecular Oncology
Table 42. Key Market Challenges & Risks of Molecular Oncology
Table 43. Key Industry Trends of Molecular Oncology
Table 44. Global Molecular Oncology Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Molecular Oncology Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Molecular Oncology Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Molecular Oncology Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Roche Diagnostics Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 49. Roche Diagnostics Molecular Oncology Product Offered
Table 50. Roche Diagnostics Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Roche Diagnostics Main Business
Table 52. Roche Diagnostics Latest Developments
Table 53. Thermo Fisher Scientific Inc. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 54. Thermo Fisher Scientific Inc. Molecular Oncology Product Offered
Table 55. Thermo Fisher Scientific Inc. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Thermo Fisher Scientific Inc. Main Business
Table 57. Thermo Fisher Scientific Inc. Latest Developments
Table 58. Illumina, Inc. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 59. Illumina, Inc. Molecular Oncology Product Offered
Table 60. Illumina, Inc. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Illumina, Inc. Main Business
Table 62. Illumina, Inc. Latest Developments
Table 63. Qiagen N.V. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 64. Qiagen N.V. Molecular Oncology Product Offered
Table 65. Qiagen N.V. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Qiagen N.V. Main Business
Table 67. Qiagen N.V. Latest Developments
Table 68. Agilent Technologies, Inc. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 69. Agilent Technologies, Inc. Molecular Oncology Product Offered
Table 70. Agilent Technologies, Inc. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Agilent Technologies, Inc. Main Business
Table 72. Agilent Technologies, Inc. Latest Developments
Table 73. Abbott Laboratories Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 74. Abbott Laboratories Molecular Oncology Product Offered
Table 75. Abbott Laboratories Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Abbott Laboratories Main Business
Table 77. Abbott Laboratories Latest Developments
Table 78. Bio-Rad Laboratories, Inc. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 79. Bio-Rad Laboratories, Inc. Molecular Oncology Product Offered
Table 80. Bio-Rad Laboratories, Inc. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Bio-Rad Laboratories, Inc. Main Business
Table 82. Bio-Rad Laboratories, Inc. Latest Developments
Table 83. Myriad Genetics, Inc. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 84. Myriad Genetics, Inc. Molecular Oncology Product Offered
Table 85. Myriad Genetics, Inc. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Myriad Genetics, Inc. Main Business
Table 87. Myriad Genetics, Inc. Latest Developments
Table 88. Genomic Health, Inc. Details, Company Type, Molecular Oncology Area Served and Its Competitors
Table 89. Genomic Health, Inc. Molecular Oncology Product Offered
Table 90. Genomic Health, Inc. Molecular Oncology Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Genomic Health, Inc. Main Business
Table 92. Genomic Health, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Molecular Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Oncology Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Molecular Oncology Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Molecular Oncology Sales Market Share by Country/Region (2025)
Figure 8. Molecular Oncology Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Molecular Oncology Market Size Market Share by Type in 2025
Figure 10. Molecular Oncology in Hospitals and Clinics
Figure 11. Global Molecular Oncology Market: Hospitals and Clinics (2021-2026) & ($ millions)
Figure 12. Molecular Oncology in Diagnostic Laboratories
Figure 13. Global Molecular Oncology Market: Diagnostic Laboratories (2021-2026) & ($ millions)
Figure 14. Molecular Oncology in Cancer Centers and Specialty Clinics
Figure 15. Global Molecular Oncology Market: Cancer Centers and Specialty Clinics (2021-2026) & ($ millions)
Figure 16. Molecular Oncology in Others
Figure 17. Global Molecular Oncology Market: Others (2021-2026) & ($ millions)
Figure 18. Global Molecular Oncology Market Size Market Share by Application in 2025
Figure 19. Global Molecular Oncology Revenue Market Share by Player in 2025
Figure 20. Global Molecular Oncology Market Size Market Share by Region (2021-2026)
Figure 21. Americas Molecular Oncology Market Size 2021-2026 ($ millions)
Figure 22. APAC Molecular Oncology Market Size 2021-2026 ($ millions)
Figure 23. Europe Molecular Oncology Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Molecular Oncology Market Size 2021-2026 ($ millions)
Figure 25. Americas Molecular Oncology Value Market Share by Country in 2025
Figure 26. United States Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Molecular Oncology Market Size Market Share by Region in 2025
Figure 31. APAC Molecular Oncology Market Size Market Share by Type (2021-2026)
Figure 32. APAC Molecular Oncology Market Size Market Share by Application (2021-2026)
Figure 33. China Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 37. India Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Molecular Oncology Market Size Market Share by Country in 2025
Figure 40. Europe Molecular Oncology Market Size Market Share by Type (2021-2026)
Figure 41. Europe Molecular Oncology Market Size Market Share by Application (2021-2026)
Figure 42. Germany Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 43. France Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Molecular Oncology Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Molecular Oncology Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Molecular Oncology Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 56. APAC Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 57. Europe Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 59. United States Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 60. Canada Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 61. Mexico Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 62. Brazil Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 63. China Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 64. Japan Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 65. Korea Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 67. India Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 68. Australia Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 69. Germany Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 70. France Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 71. UK Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 72. Italy Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 73. Russia Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 74. Egypt Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 75. South Africa Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 76. Israel Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 77. Turkey Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 78. Global Molecular Oncology Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Molecular Oncology Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 1. Molecular Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Oncology Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Molecular Oncology Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Molecular Oncology Sales Market Share by Country/Region (2025)
Figure 8. Molecular Oncology Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Molecular Oncology Market Size Market Share by Type in 2025
Figure 10. Molecular Oncology in Hospitals and Clinics
Figure 11. Global Molecular Oncology Market: Hospitals and Clinics (2021-2026) & ($ millions)
Figure 12. Molecular Oncology in Diagnostic Laboratories
Figure 13. Global Molecular Oncology Market: Diagnostic Laboratories (2021-2026) & ($ millions)
Figure 14. Molecular Oncology in Cancer Centers and Specialty Clinics
Figure 15. Global Molecular Oncology Market: Cancer Centers and Specialty Clinics (2021-2026) & ($ millions)
Figure 16. Molecular Oncology in Others
Figure 17. Global Molecular Oncology Market: Others (2021-2026) & ($ millions)
Figure 18. Global Molecular Oncology Market Size Market Share by Application in 2025
Figure 19. Global Molecular Oncology Revenue Market Share by Player in 2025
Figure 20. Global Molecular Oncology Market Size Market Share by Region (2021-2026)
Figure 21. Americas Molecular Oncology Market Size 2021-2026 ($ millions)
Figure 22. APAC Molecular Oncology Market Size 2021-2026 ($ millions)
Figure 23. Europe Molecular Oncology Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Molecular Oncology Market Size 2021-2026 ($ millions)
Figure 25. Americas Molecular Oncology Value Market Share by Country in 2025
Figure 26. United States Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Molecular Oncology Market Size Market Share by Region in 2025
Figure 31. APAC Molecular Oncology Market Size Market Share by Type (2021-2026)
Figure 32. APAC Molecular Oncology Market Size Market Share by Application (2021-2026)
Figure 33. China Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 37. India Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Molecular Oncology Market Size Market Share by Country in 2025
Figure 40. Europe Molecular Oncology Market Size Market Share by Type (2021-2026)
Figure 41. Europe Molecular Oncology Market Size Market Share by Application (2021-2026)
Figure 42. Germany Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 43. France Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Molecular Oncology Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Molecular Oncology Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Molecular Oncology Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Molecular Oncology Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 56. APAC Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 57. Europe Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 59. United States Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 60. Canada Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 61. Mexico Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 62. Brazil Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 63. China Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 64. Japan Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 65. Korea Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 67. India Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 68. Australia Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 69. Germany Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 70. France Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 71. UK Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 72. Italy Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 73. Russia Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 74. Egypt Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 75. South Africa Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 76. Israel Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 77. Turkey Molecular Oncology Market Size 2027-2032 ($ millions)
Figure 78. Global Molecular Oncology Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Molecular Oncology Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Molecular Oncology Market Size 2027-2032 ($ millions)
